Goldenwell Biotech, Inc. (GWLL)

Market Cap	68.28M +244.9%
Revenue (ttm)	55.00 -60.4%
Net Income	-282.12K
EPS	-0.00
Shares Out	99.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	925
Open	0.6897
Previous Close	0.6897
Day's Range	0.5200 - 0.6897
52-Week Range	0.3880 - 10.0000
Beta	4.81
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Goldenwell Biotech

Goldenwell Biotech, Inc. engages in the nutraceutical and dietary supplements business. It offers JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2019
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: GWLL

Financial Performance

In 2025, Goldenwell Biotech's revenue was $55, a decrease of -60.43% compared to the previous year's $139. Losses were -$296,471, 125.5% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 12, 2026

Data Sources Report a data error